Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Sleep Disorders Channel is supported through educational grants from Alkermes and Takeda.

VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.

Share this video  

Sleep Europe 2026 | Rethinking diagnostic criteria in NT2 and IH: sleep inertia and other potential biomarkers

Jari Gool, MD, Amsterdam UMC, Amsterdam, Netherlands, discusses work from the European Narcolepsy Network database suggesting that narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) are not distinct entities, as their diagnostic criteria are not clear-cut and many patients change diagnosis on repeat testing. Dr Gool explains that a data-driven clustering study identified sleep inertia and longer sleep duration on weekends compared with weekdays as potential biomarkers for phenotypic classification, further research is needed before they could inform future diagnostic criteria. This interview took place at Sleep Europe 2026, which was held in Maastricht, Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.